From Macleans:
People with bone marrow cancer who fail standard treatments may live longer thanks to a new drug called bortezomib.
Bone marrow cancer, or multiple myeloma, will be diagnosed in 1,850 Canadians this year, according to the Canadian Cancer Society. An estimated 1,250 will die from the disease.
Dr. Joseph Connor, chairman of the lymphoma treatment group at the B.C. Cancer Agency, says that for multiple myeloma patients who have failed standard treatments such as bone marrow stem cell transplantation or chemotherapy, bortezomib can help 30 to 40 per cent get better and stay better for months and possibly years. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment